The Value of PD-L1 Expression in Predicting the Efficacy of Anti-PD-1 or Anti-PD-L1 Therapy in Patients with Cancer: A Systematic Review and Meta-Analysis.
Xiao-Jiang ChenShu-Qiang YuanJin-Ling DuanYong-Ming ChenShi ChenYun WangYuan-Fang LiPublished in: Disease markers (2020)
We recommend PD-L1 expression as a predictive biomarker in patient selection for anti-PD-1/PD-L1 monotherapy, but not for combination therapies.